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Juniperus and Cupressus genera are mainly used as diuretic, stimulant, and antiseptic, for common cold and wound healing in
Turkish folk medicine. In the present study, essential oils obtained from cones of Cupressus and berries of Juniperus were evaluated
for their wound healing and anti-inﬂammatory eﬀects. In vivo wound healing activity was evaluated by linear incision and circular
excision experimental wound models, assessment of hydroxyproline content, and subsequently histopathological analysis. The
healing potential was comparatively assessed with a reference ointment Madecassol. Additionally acetic-acid-induced capillary
permeability test was used for the oils’ anti-inﬂammatory activity. The essential oils of J. oxycedrus subsp. oxycedrus and J.
phoenicea demonstrated the highest activities, while the rest of the species did not show any signiﬁcant wound healing eﬀect.
The experimental study revealed that J. oxycedrus subsp. oxycedrus and J. phoenicea display remarkable wound healing and anti-
inﬂammatory activities, which support the folkloric use of the plants.
1.Introduction
Juniperus L.(Cupressaceae)hasalmost70speciesthroughout
the world and are mostly distributed in the Northern Hemi-
sphere [1]. The widespread areas extend from Japan and East
A s i at oE u r o p e ,a sw e l la sf r o mN o r t ha n dE a s tA f r i c at o
North America. In Turkey, the Juniperus genus is represented
by 10 taxa under seven speciess and has also been used by
Anatolian people since ancient times. Fruits of Juniperus spe-
cies are used to produce pekmez (a traditional Turkish fruit
concentrate), which is rich in nutritional constituents [2].
Juniper berries are used in Northern European countries to
impart sharp and clear ﬂavour to the meat dishes [3, 4].
The coniferous parts and leaves of Juniperus are utilized
in medicine as an antihelmintic, diuretic, stimulant, and
antiseptic and for wound healing. J. excelsa is used against
tuberculosis and jaundice [5]. The literature survey indicates
that the major phenolic constituents in extracts of Juniperus
species are lignans, coumarins, sesquiterpenes, abietane,
labdane and pimarane diterpenes, ﬂavonoids, biﬂavonols,
ﬂavone glycosides, and tannins [1].
The genus Cupressus is one of several genera within the
family Cupressaceae. Based on genetic and morphological
analysis, the Cupressus is found in the Cupressoideae sub-
family [6]. They are widespread in the northern hemisphere,
including western North America, Central America, north-
west Africa, the Middle East, the Himalaya, southern China,
and north Vietnam. They are evergreen trees or large shrubs,
growing to 5–40m tall. In Turkish folk medicine, fruits of
Cupressus sempervirens are used to treat common cold and
cough [7]. In previous studies, the major constituents have
been identiﬁed in Cupressus species as α-pinene and Δ-3-
carene [8]. The leaves and fruits of this plant are quite rich in
tannins and ﬂavonoids but they are free from alkaloids and
low in saponins [9].
The aim of the present study is to evaluate the wound
healing activity of the oils from cones of Cupressus semper-
virens var. horizontalis and C. sempervirens var. pyramidalis2 Evidence-Based Complementary and Alternative Medicine
Table 1: Sampling site, local name, date, and altitude of the tree species.
Species Sampling site Local name Collection date Altitude
Cupressus sempervirens var. horizontalis Antalya-Turkey Dallı Servi October, 2010 670m
Cupressus sempervirens var. pyramidalis Antalya-Turkey Piramid Servi October, 2010 650m
Juniperus communis L. subsp. nana Syme. Keltepe-Karab¨ uk Bodur Ardıc ¸ September, 2010 1,210m
Juniperus excelsa Bieb. Silifke-Mersin Boylu Ardıc ¸ October, 2010 220m
Juniperus foetidissima Willd. Beypazarı-Ankara Kokulu Ardıc ¸ October, 2010 240m
Juniperus oxycedrus L. subsp. oxycedrus Keltepe-Karab¨ uk Katran Ardıcı September, 2010 1,200m
Juniperus phoenicea L. Bodrum-Yokusbasi Finike Ardıcı September, 2010 170m
Table 2: Eﬀects of the essential oils from C. sempervirens var. hori-
zontalis, C. sempervirens var. pyramidalis, J. communis, J. excelsa, J.
foetidissima, J. oxycedrus, and J. phoenicea on linear incision wound
model.
Material Statistical mean ± SEM
(tensile strength %)
Vehicle 13.24 ± 2.25
(9.1)
Negative control 12.14 ± 2.54
—
Cupressus sempervirens var. horizontalis 14.51 ± 2.17
(9.6)
Cupressus sempervirens var. pyramidalis 14.27 ± 2.09
(7.8)
J. communis subsp. nana 13.82 ± 2.04
(4.4)
Juniperusexcelsa 15.27 ± 2.43
(15.3)
Juniperusfoetidissima 14.66 ± 1.86
(10.7)
Juniperus oxycedrus subsp. oxycedrus 17.41 ± 2.19
(31.5)∗∗
Juniperusphoenicea 18.05 ± 2.26
(36.3)∗∗
Madecassol 19.87 ± 1.41
(50.1)∗∗∗
∗P<0.05; ∗∗P<0.01; ∗∗∗P<0.001; SEM: Standard error of the
mean.
Percentageoftensilestrengthvalues:vehiclegroupwascomparedtonegative
control group; the oils and the reference material were compared to vehicle
group.
and berries of J. communis, J. excelsa, J. foetidissima, J. oxyce-
drus, and J. phoenicea by means of in vivo circular excision
and linear incision wound models and anti-inﬂammatory
activity.
2.MaterialsandMethods
2.1. Plant Material. Berries and cones of 5 diﬀerent Juniper
species and 2 diﬀerent varieties of Cypress belonging to Cup-
ressaceae family natively growing in Turkey were chosen as
the study material. Specimens were taken from each species
as 1kg weight from their growth sites and stored at −24◦C
until analysis [10]. Species names, sampling site, local name,
collection date, and altitude of all specimens are listed in
Table 1.
2.2. Hydrodistillation. The essential oils of each sample were
obtained by hydrodistillation with a Clevenger apparatus us-
ing 250g (partially crushed) of fresh berries and cones. The
essential oils were collected for 3h and dried over anhydrous
sodiumsulphateandunderrefrigerationinasealedvialuntil
required [11, 12].
2.3. Biological Activity Tests
2.3.1. Animals. Male, Sprague-Dawley rats (160–180g) and
Swiss albino mice (20–25g) were purchased from the animal
breeding laboratory of Saki Yenilli (Ankara, Turkey).
The animals were left for 3 days at room conditions for
acclimatization. They were maintained on standard pellet
dietandwateradlibitumthroughouttheexperiment.Amin-
imum of six animals were used in each group. Throughout
the experiments, animals were processed according to the
suggested European ethical guidelines for the care of labor-
atory animals.
2.3.2. Preparation of Test Samples for Bioassay. Incision and
excision wound models were used to evaluate the wound
healing activity. For the in vivo wound models, test samples
were prepared in an ointment base (vehicle) consisting of
glycol stearate, 1, 2 propylene glycol, liquid paraﬃn( 3:6:1 )
in 1% concentration. 0.5g of each test ointment was applied
topically on the wounded site immediately after wound was
created by a surgical blade.
The animals of the vehicle group were treated with the
ointment base only, whereas the animals of the reference
drug group were treated with 0.5g of Madecassol (Bayer,
00001199). Madecassol contains 1% extract of Centella
asiatica.
For the assessment of anti-inﬂammatory activity, test
samples were given orally to test animals after suspending in
a mixture of distilled H2O and 1% Tween 80. The control
group animals received the same experimental handling as
those of the test groups except that the drug treatment was
replaced with appropriate volumes of dosing vehicle. Indo-
methacin (10mg/kg) in 1% Tween 80 was used as reference
drug.Evidence-Based Complementary and Alternative Medicine 3
Table 3: Eﬀects of the essential oils from C. sempervirens var. horizontalis, C. sempervirens var. pyramidalis, J. communis, J. excelsa, J. foetid-
i s s i m a ,J .o x y c e d r u s ,and J. phoenicea on circular excision wound model.
Material
Wound area ± SEM (contraction %)
02468 1 0 1 2
Vehicle 19.55 ± 2.09 17.98 ± 2.20
(2.55)
16.54 ± 2.11
—
14.89 ± 1.95
—
9.55 ± 1.56
(9.51)
6.31± 1.16
(8.42)
2.97 ± 0.87
(5.41)
Negative Control 19.43 ± 2.15 18.45 ± 2.23 16.42 ± 2.17 14.72 ± 1.91 10.51 ± 1.75 6.89 ± 1.23 3.14 ± 1.49
C. sempervirens var.
horizontalis 19.40 ± 2.13 17.56 ± 1.40
(2.34)
16.02 ± 1.50
(3.14)
14.91 ± 1.62
—
9.57 ± 1.40
—
5.86 ± 1.32
(7.13)
3.56 ± 0.69
—
C. sempervirens var.
pyramidalis 20.03 ± 2.12 17.90 ± 1.91
(0.44)
16.69 ± 1.92
—
14.92 ± 1.60
—
8.84 ± 1.67
(7.43)
7.08 ± 1.12
—
2.59 ± 0.84
(12.79)
J. communis subsp. nana
Syme. 19.55 ± 2.22 17.81 ± 1.81
(5.56)
16.75 ± 1.80
—
15.16 ± 1.87
—
9.57 ± 1.74
—
6.02 ± 0.99
(4.60)
3.04 ± 0.89
—
J.excelsa 19.50 ± 2.16 14.99 ± 1.78
(16.63)
13.24 ± 2.09
(19.95)
11.26 ± 1.70
(24.38)
7.39 ± 1.58
(22.62)
5.47 ± 1.07
(13.31)
2.44 ± 0.90
(17.85)
J. foetidissima 19.96 ± 2.51 16.16 ± 1.89
(10.12)
14.02 ± 1.78
(15.24)
13.49 ± 1.71
(9.40)
9.09 ± 1.54
(4.82)
6.10 ± 1.27
(3.33)
2.49 ± 1.05
(16.16)
J. oxycedrus subsp.
oxycedrus 19.41 ± 2.08 17.51 ± 1.92
(2.61)
16.02 ± 1.70
(6.05)
12.62 ± 1.63
(15.25)
6.03 ± 1.03
(36.86)∗
3.85 ± 0.96
(38.99)∗
1.69 ± 0.60
(43.10)∗
J. phoenicea 19.59 ± 2.19 16.46 ± 2.54
(8.45)
14.02 ± 1.96
(15.24)
11.97 ± 1.86
(19.61)
7.44 ± 1.39
(22.09)
4.21 ± 1.28
(33.28)∗
1.76 ± 0.61
(40.74)∗
Madecassol 19.68 ± 2.03 14.46 ± 1.83
(19.58)
11.77 ± 1.45
(28.84)
8.76 ± 1.21
(41.17)∗∗
4.74 ± 0.89
(50.37)∗∗
2.12 ± 0.31
(66.40)∗∗∗
0.00 ± 0.00
(100.00)∗∗∗
∗P<0.05; ∗∗P<0.01; ∗∗∗P<0.001; SEM: standard error of the mean.
Percentage of contraction values: vehicle group was compared to negative control group; the oils and the reference material were compared to vehicle group.
Table 4: Eﬀect of topical treatment of test ointments for 7 days on
hydroxyproline content.
Material Hydroxyproline
(mg/g) ± SEM
Vehicle 20.21 ± 2.43
Negative Control 19.25 ± 2.67
C. sempervirens var. horizontalis 18.3 ± 2.41
C. sempervirens var. pyramidalis 25.9 ± 3.17
J. communis subsp. nana 24.3 ± 3.52
J.excelsa 29.5 ± 3.01
J. foetidissima 21.8 ± 2.54
J. oxycedrus subsp. oxycedrus 50.8 ± 2.44∗∗
J.phoenicea 44.3 ± 2.81∗
Madecassol 75.6 ± 2.95∗∗∗
∗P<0.05; ∗∗P<0.01; ∗∗∗P<0.001;SEM:standarderrorofthemean.
2.3.3. Wound Healing Activity
Linear Incision Wound Model. Animals, seven rats in each
group, were anaesthetized with 0.15cc Ketalar [13], and the
hairs on the dorsal part of the rats were shaved and cleaned
with 70% alcohol. Two 5cm length linear-paravertebral in-
cisions were made with a sterile blade through the shaved
skinatthedistanceof1.5cmfromthedorsalmidlineoneach
side. Three surgical sutures were placed each 1cm apart.
The ointments prepared with test samples, the reference
drug (Madecassol) or ointment base (glycol stearate: propy-
lene glycol: liquid paraﬃn (3:6:1)) were topically applied
on the dorsal wounds in each group of animals once daily
throughout 9 days. All the sutures were removed on the last
day, and tensile strength of previously wounded and treated
skin was measured by using a tensiometer (Zwick/Roell Z0.5,
Germany) [14, 15].
Circular Excision Wound Model. This model was used to
monitor wound contraction and wound closure time. Each
group of animals (seven animals in each) was anaesthetized
by 0.01cc Ketalar. The back hairs of the mice were depilated
by shaving. The circular wound was created on the dorsal
interscapular region of each animal by excising the skin with
a 5mm biopsy punch; wounds were left open (Tramontina,
Machado, Nogueira Filho Gda, Kim, Vizzioli & Toledo,
2002). Test samples, the reference drug (Madecassol, Bayer)
and the vehicle ointments were applied topically once a
day till the wound was completely healed. The progressive
changes in wound area were monitored by a camera (Fuji,
S20 Pro, Japan) every other day. Later on, wound area was
evaluated by using AutoCAD program. Wound contraction
was calculated as percentage of the reduction in wounded
area. A specimen sample of tissue was isolated from the
treated skin of each group of mice for the histopathological
examination [16].
2.3.4. Hydroxyproline Estimation. Tissues were dried in hot
airovenat60–70◦Ctillconsistentweightwasachieved.After-
wards, samples were hydrolyzed with 6N HCl for 4 hours at
130◦C. The hydrolyzed samples were adjusted to pH 7 and
subjected to chloramine T oxidation. The coloured adduct
formedwithEhrlichreagentat60◦Cwasreadat557nm[17].4 Evidence-Based Complementary and Alternative Medicine
Table 5: Wound healing processes and healing phases of the vehicle, negative control, test ointments, and Madecassol-administered animals.
Groups Wound healing processes
Vehicle S U RE FP CD MNC PMN NV
Negative control ++/+++ +++ — ++/+++ ++ +++ ++/+++ ++
C. sempervirens var. horizontalis ++/+++ ++/+++ — ++/+++ ++ ++ ++/+++ ++/+++
C. sempervirens var. pyramidalis ++ ++/+++ — ++ ++ +/++ ++ ++
J. communis subsp. nana Syme. ++/+++ ++/+++ — ++/+++ ++ +/++ ++ +++
J.excelsa ++/+++ ++/+++ — ++ +/++ ++ ++ +/++
J. foetidissima +/++ +/++ −/+ ++ +/++ +/++ +/++ ++
J. oxycedrus subsp. oxycedrus ++ +/++ −/+ ++ +/++ +/++ +/++ +/++
J. phoenicea +/++ +/++ −/+ ++ +/++ +/++ +/++ ++
Madecassol +/++ −/+ + ++ +/++ + +/++ +/++
HE- and VG-stained sections were scored as mild (+), moderate (++), and severe (+++) for epidermal and/or dermal remodeling. S: scab, U: ulcer, RE: re-
epithelization, FP: ﬁbroblast proliferation, CD: collagen depositions, MNC: mononuclear cells, PMN: polymorphonuclear cells, NV: neovascularization, I:
inﬂammation phase, P: proliferation phase, and R: remodeling phase.
Table 6: Inhibitory eﬀect of the essential oils from C. sempervirens var. horizontalis, C. sempervirens var. pyramidalis, J. communis, J. excelsa,
J. foetidissima, J. oxycedrus, and J. phoenicea on acetic-acid-induced increased capillary permeability.
Material Dose (mg/kg) Evans blue concentration (μg/mL) ± SEM Inhibition (%)
Control 10.69 ± 0.86
Cupressus sempervirens var. horizontalis 100 10.40 ± 0.95 2.7
200 10.12 ± 0.74 5.3
Cupressus sempervirens var. pyramidalis 100 10.75 ± 0.87 —
200 11.16 ± 0.91 —
Juniperus communis ssp. nana 100 10.13 ± 0.79 5.2
200 10.01 ± 0.38 6.4
Juniperus excelsa 100 10.57 ± 0.88 1.1
200 9.04 ± 0.85 15.4
Juniperus foetidissima 100 12.27 ± 0.95 —
200 11.25 ± 0.99 —
Juniperus oxycedrus ssp. oxycedrus 100 8.82 ± 0.76 17.5
200 7.15 ± 0.32 33.1∗∗
Juniperus phoenicea 100 9.04 ± 0.89 15.4
200 7.77 ± 0.44 27.3∗
Indomethacin 10 5.28 ± 0.26 50.6∗∗∗
∗P<0.05; ∗∗P<0.01; ∗∗∗P<0.001 signiﬁcant from the control; SEM: standard error of the mean.
Standard hydroxyproline was also run and values reported as
mg/g dry weight of tissue [18].
2.3.5. Histopathology. The skin specimens from each group
were collected at the end of the experiment. Samples were
ﬁxed in 10% buﬀered formalin, processed, and blocked with
paraﬃn and then sectioned into 5 micrometer sections and
stained with hematoxylin & eosin (HE) and Van Gieson
(VG) stains. The tissues were examined by light microscope
(Olympus CX41 attached Kameram Digital Image Analyze
System) and graded as mild (+), moderate (++), and
severe (+++) for epidermal or dermal remodeling. Re-epi-
thelization or ulcer in epidermis, ﬁbroblast proliferation,
mononuclear and/or polymorphonuclear cells, neovascular-
ization, and collagen depositions in dermis were analyzed
to score the epidermal or dermal remodeling. At the end
of the examination, wound healing phases—inﬂammation,
proliferation, and remodeling—were determined for all
groups.
2.3.6. Anti-Inﬂammatory Activity
A c eti c - A ci d - I n d u c e dI n cr e a sei nC a p i l l a ryP erm e a b i l i ty . Eﬀect
of the test samples on the increased vascular permeability
induced by acetic acid in mice was determined according
to Whittle method [19] with some modiﬁcations [20].
Each test sample was administered orally to a group of 10
mice in 0.2mL/20g body weight. Thirty minutes after the
administration, the tail of each animal was injected with
0.1mL of 4% Evans blue in saline solution (intravenous) and
thenwewaitedfor10min.Then,0.4mLof0.5%(v/v)AcOH
was injected intraperitoneally. After 20min incubation, the
mice were killed by dislocation of the neck, and the viscera
were exposed and irrigated with distilled water, which was
thenpouredinto10mLvolumetricﬂasksthroughglasswool.Evidence-Based Complementary and Alternative Medicine 5
Figure 1: Histopathological view of wound healing and epidermal/dermal remodeling in the vehicle, negative control, oils, and reference
ointment Madecassol-administered animals. Skin sections show the hematoxylin & eosin- (HE-) stained epidermis and dermis in A and the
dermis stained with Van Gieson (VG) in B. The original magniﬁcation was ×100 and the scale bars represent 120μm for ﬁgures in A, and the
original magniﬁcation was ×400 and the scale bars represent 40 μm for B. Data are representative of 6 animals per group. (1) Vehicle group:
10-day-oldwoundtissuetreatedwithonlyvehicle,(2)negativecontrolgroup:10-day-oldwoundtissue,untreatedgroup,(3)C.sempervirens
var. horizontalis group: 10-day-old wound tissue treated with the essential oil of C. sempervirens var. horizontalis,( 4 )C. sempervirens var.
pyramidalis group, 10 day old wound tissue treated with essential oil of C. sempervirens var. pyramidalis,( 5 )J. communis group: 10-day-old
wound tissue treated with essential oil of J. communis,( 6 )J. excelsa group: 10-day-old wound tissue treated with essential oil of J. excelsa,
(7) J. foetidissima group: 10-day-old wound tissue treated with essential oil of J. foetidissima,( 8 )J. oxycedrus group: 10-day-old wound
tissue treated with essential oil of J. oxycedrus,( 9 )J. phoenicea group: 10-day-old wound tissue treated with essential oil of J. phoenicea,a n d
(10) reference group: 10-day-old wound tissue treated with Madecassol. Arrows pointing events during wound healing; s: scab, u: ulcer, re:
re-epithelization, f: ﬁbroblast, c: collagen, mnc: mononuclear cells, pmn: polymorphonuclear cells, and nv: neovascularization.
Each ﬂask was made up to 10mL with distilled water, 0.1mL
of 0.1N NaOH solution was added to the ﬂask, and the
absorption of the ﬁnal solution was measured at 590nm
(Beckmann Dual Spectrometer; Beckman, Fullerton, Calif,
USA). A mixture of distilled water and 0.5% CMC was given
orally to control animals, and they were treated in the same
manner as described above.
2.3.7. Statistical Analysis of the Data. The data on percent-
age anti-inﬂammatory and wound healing was statistically
analyzed using one-way analysis of variance (ANOVA). The
values of P ≤ 0.05 were considered statistically signiﬁcant.
Histopathologic data were considered to be nonparamet-
ric; therefore, no statistical tests were performed.
3. Results andDiscussion
In the present study, wound healing and anti-inﬂammatory
eﬀects of the oils obtained from Cupressus sempervirens var.
horizontalis, C. sempervirens var. pyramidalis J. communis,
J. excelsa, J. foetidissima, J. oxycedrus,a n dJ. phoenicea were
evaluated. The oils were mixed with glycol stearate, 1,2 pro-
pylene glycol, liquid paraﬃn (3:6:1) in 1% concentration
for the assessment of the wound healing activity. Linear
incision and circular excision experimental wound models
were employed. Moreover, skin samples were evaluated
histopathologically. The experimental results are given in
Tables 2–6.
As shown in Table 2, topical application of the ointment
prepared with the oils of aerial parts of J. oxycedrus subsp.
oxycedrus and J. phoenicea onto the incised wounds demon-
strated the best wound healing activity. On day 10 the ten-
sile strength values were 31.5% and 36.3%, respectively. The
rest of the oils did not show any remarkable wound healing
activity.
The contraction values of vehicle, negative control, oils
andreferencedrugtreatedgroupswereshowninTable 3.The
oilsobtainedfromtheberries of J.oxycedrussubsp.oxycedrus
andJ.phoeniceawerefoundtohavewoundhealingpotential,
while the vehicle and negative control groups and the other
oil ointments showed no statistically signiﬁcant wound heal-
ing activity. The wound contractions were determined as6 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Healing phases of the vehicle, negative control, test
ointments, and Madecassol-administered animals.
38.99% and 43.10% for J. oxycedrus subsp. oxycedrus and
33.28% and 40.74% for J. phoenicea when compared to
reference drug Madecassol (90.78%–100%).
For the assessment of collagen synthesis hydroxyproline
levels of treated tissues were evaluated. As shown in Table 4
signiﬁcant increase in hydroxyproline content was observed
for the tissues treated with the essential oils of J. oxycedrus
ssp. oxycedrus and J. phoenicea.
Phases in wound healing processes (inﬂammation, pro
liferation, and remodeling) were observed and within
the experimental groups with diﬀerent degree (Table 5,
Figures 1 and 2). The reference drug, essential oils of J.
oxycedrus subsp. oxycedrus and J. phoenicea treated groups
demonstrated faster remodeling respectively compared to
the other groups which showed delayed wound healing
processes. As an evidence of delay, wound-associated tissue
debris still remained in the dermal tissues.
The eﬀect of the extracts on the inﬂammatory phase
of wound healing was examined by using the method
of Whittle, based on the inhibition of acetic-acid-induced
capi-llary permeability. As shown in Table 6, the inhibitory
activity was observed for the oils from Juniperus oxycedrus
ssp. oxycedrus and J. phoenicea at the dose of 200mg/kg
with the highest inhibitory values of 33.1% and 27.3%,
respectively,whiletheessentialoilsfrombothspeciesshowed
no signiﬁcant eﬀect at the dose of 100mg/kg. On the other
hand the rest of the oils did not show any inhibitory activity.
Previous studies revealed that the essential oils of
Juniperus and Cupressus are rich in α-pinene. Particularly J.
phoenicea possesses the highest α-pinene content compared
to the other species in comparative phytochemical analysis;
β-Pinene, sabinene, and limonene are the constituents which
are also present in the essential oils of both genera [8, 10].
In a previous study, α-pinene was found to have moderate
anti-inﬂammatory eﬀect at 500mg/kg dose on carrageenan-
induced hind paw edema test [21]. Anti-inﬂammatory
activity is essential for wound healing, since a long duration
in the inﬂammatory phase causes a delay in healing process.
In order to shorten the healing period as well as for minimal
pain and scar, anti-inﬂammatory activity is required [22].
Presence of α-pinene in Juniperus species could probably
contribute to wound healing activity by providing anti-
inﬂammatory eﬀect. Moreover, limonene is an important
monoterpene which has a role in wound healing [23]. In a
model of chronic skin inﬂammation, the researchers have
also shown a signiﬁcant eﬀect of limonene and perillyl alco-
holonskinrepairandproinﬂammatorycytokineslevels[24].
Furthermore, J. oxycedrus ssp. oxycedrus and J. phoenicea
were found to have high ﬂavonoid and phenolic acid content
which provide them to show remarkable antioxidant activity
[5].Asinmanyofthediseases,antioxidant activityalsohelps
to promote wound healing process [25].
Collagen is an important extracellular matrix pro-
tein which provides strength and integrity to the tissue
and plays an important role in haemostasis and epithelisa-
tion. High levels of hydroxyproline in regenerated tissue sug-
gest enhanced collagen synthesis. Hence enhanced collagen
synthesis by J. oxycedrus ssp. oxycedrus and J. phoenicea may
signiﬁcantlycontributetohealingandprovidestrengthtore-
paired tissue [18].
4. Conclusion
According to the experimental results, the oils from berries
of J. oxycedrus ssp. oxycedrus and J. phoenicea were found
to have better activity on the wound healing compared to
the other essential oils and control groups. This might be
due to the synergistic eﬀect of the constituents present in the
oils. This study provides a scientiﬁc evidence for the folkloric
utilization of Juniperus for wound healing activity.
References
[1] G. Topc ¸ u ,R .E r e n l e r ,O .C ¸akmak et al., “Diterpenes from the
berries of Juniperus excelsa,” Phytochemistry,v o l .5 0 ,n o .7 ,p p .
1195–1199, 1999.
[2] I. Akinci, F. Ozdemir, A. Topuz, O. Kabas, and M. Canakci,
“Some physical and nutritional properties of Juniperus dru-
pacea fruits,” Journal of Food Engineering,v o l .6 5 ,n o .3 ,p p .
325–331, 2004.
[3] P. Montagne, The Concise Larousse Gastronomique,H a m l y n ,
London, UK, 1999.
[4] M. R. Loizzo, R. Tundis, F. Conforti, A. M. Saab, G. A. Statti,
and F. Menichini, “Comparative chemical composition, anti-
oxidant and hypoglycaemic activities of Juniperus oxycedrus
ssp. oxycedrus L. berry and wood oils from Lebanon,” Food
Chemistry, vol. 105, no. 2, pp. 572–578, 2007.
[5] M. ¨ Ozt¨ urk, I. T¨ u m e n ,A .U ˘ gur, F. Aydo˘ gmus ¸-¨ Ozt¨ urk, and
G. Topc ¸u, “Evaluation of fruit extracts of six Turkish Juni-
perus species for their antioxidant, anticholinesterase and
antimicrobial activities,” Journal of the Science of Food and
Agriculture, vol. 91, no. 5, pp. 867–876, 2011.
[6] P. A. Gadek, D. L. Alpers, M. M. Heslewood, and C. J. Quinn,
“Relationships within Cupressaceae sensu lato: a combinedEvidence-Based Complementary and Alternative Medicine 7
morphological and molecular approach,” American Journal of
Botany, vol. 87, no. 7, pp. 1044–1057, 2000.
[7] E. Yes ¸ilada, E. Sezik, G. Honda, Y. Takaishi, Y. Takeda, and T.
Tanaka, “Traditional medicine in Turkey IX: folk medicine in
north-west Anatolia,” Journal of Ethnopharmacology, vol. 64,
no. 3, pp. 195–210, 1999.
[8] I. Tumen, T¨ urkiye’de Yetisen Juniperus spp. T¨ urlerinin Igne
Yaprak, Meyve ve Kozalaklarinin Kimyasal Bilesenleri,D o k t o r a
Tezi, Zonguldak Karaelmas ¨ Universitesi, Zonguldak, Turkey,
2005.
[ 9 ]S .A .E m a m i ,M .H .K h a y y a t ,M .R a h i m i z a d e h ,S .B .F a z l y -
Bazzaz, and J. Assilia, “Chemical constituents of Cupressus
sempervirens L. cv. Cereiformis Rehd. essential oils,” Iranian
Journal of Pharmaceutical Sciences, vol. 1, no. 1, pp. 39–42,
2004.
[10] I. Tumen, H. Haﬁzoglu, H. Kollmannsberger, B. Zimmer-
mann, A. Keskiner, and H. C. Gultekin, “Essential oil of leaves
Juniperus ssp. Natively grown in Turkey,” Pharmacognosy
Magazine, vol. 6, pp. 22–137, 2010.
[11] I. T¨ umen and M. Reunanen, “A comparative study on turpen-
tine oils of oleoresins of Pinus sylvestris L. from three districts
of Denizli,” Records of Natural Products, vol. 4, no. 4, pp. 224–
229, 2010.
[12] I. Tumen, H. Haﬁzoglu, A. Pranovich, and M. Reunanen,
“Chemical constituentsofconesandleavesofcypress(Cupres-
sussempervirensL.)growninTurkey,”FreseniusEnvironmental
Bulletin, vol. 19, no. 10, pp. 2268–2276, 2010.
[13] B. S. Shetty, S. L. Udupa, A. L. Udupa, and S. N. Somayaji,
“Eﬀect of Centella asiatica L (Umbelliferae) on normal and
dexamethasone-suppressed wound healing in Wistar albino
rats,” International Journal of Lower Extremity Wounds, vol. 5,
no. 3, pp. 137–143, 2006.
[14] S. Lodhi, R. S. Pawar, A. P. Jain, and A. K. Singhai, “Wound
healing potential of Tephrosia purpurea (Linn.) Pers. in rats,”
Journal of Ethnopharmacology, vol. 108, no. 2, pp. 204–210,
2006.
[15] L. Suguna, S. Singh, P. Sivakumar, P. Sampath, and G. Chan-
drakasan, “Inﬂuence of Terminalia chebula on dermal wound
healing in rats,” Phytotherapy Research, vol. 16, no. 3, pp. 227–
231, 2002.
[16] F. Sadaf, R. Saleem, M. Ahmed, S. I. Ahmad, and Navaid-ul-
Zafar,“HealingpotentialofcreamcontainingextractofSphae-
ranthus indicus on dermal wounds in Guinea pigs,” Journal of
Ethnopharmacology, vol. 107, no. 2, pp. 161–163, 2006.
[17] J. F. Woessner, “The determination of hydroxyproline in tissue
and protein samples containing small proportions of this
imino acid,” Archives of Biochemistry and Biophysics, vol. 93,
no. 2, pp. 440–447, 1961.
[18] A.M. Rasik, R.Raghubir, A.Gupta et al., “Healing potential of
Calotropis procera on dermal wounds in Guinea pigs,” Journal
of Ethnopharmacology, vol. 68, no. 1–3, pp. 261–266, 1999.
[19] B. A. Whittle, “The use of changes in capillary permeability in
mice to distinguish between narcotic and non-narcotic anal-
gesics,” British Journal of Pharmacology and Chemotherapy,
vol. 22, pp. 246–253, 1964.
[20] E. Yesilada and E. K¨ upeli, “Clematis vitalba L. aerial part
exhibits potent anti-inﬂammatory, antinociceptive and anti-
pyretic eﬀects,” Journal of Ethnopharmacology, vol. 110, no. 3,
pp. 504–515, 2007.
[21] I. Orhan, E. K¨ upeli, M. Aslan, M. Kartal, and E. Yesilada,
“Bioassay-guided evaluation of anti-inﬂammatory and anti-
nociceptive activities of pistachio, Pistacia vera L,” Journal of
Ethnopharmacology, vol. 105, no. 1-2, pp. 235–240, 2006.
[22] R. A. F. Clark, Cutaneous Wound Repair, Oxford University,
New York, NY, USA, 1991.
[23] S.AdamsandT.P.Thrash,“Methodsforwoundtreatmentand
healing using limonene-based compositions,” International
Application WO2010/062933 A1, Patent Cooperation Treaty,
2010.
[24] P. L. Stanley, S. Steiner, M. Havens, and K. M. Tramposch,
“Mouse skin inﬂammation induced by multiple topical
applications of 12-O-tetradecanoylphorbol-13-acetate,” Skin
Pharmacology, vol. 4, no. 4, pp. 262–271, 1991.
[25] I. Pesin, U. Koca, H Keles ¸, and E. K. Akkol, “Wound healing
activityofRubus sanctus Schreber(Rosaceae):preclinicalstudy
in animal models,” Evidence Based Complementary and Alter-
native Medicine, vol. 2011, Article ID 816156, 6 pages, 2011.